# Artesian Resources Corp: financial statements, quarterly

ARTNA · Nasdaq · CIK 863110 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/artna.md) · [Financials](/companies/artna/financials.md) · [Filings](/companies/artna/filings.md) · [Insiders](/companies/artna/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/artna/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [26.6](/filings/0000863110-24-000044.md) | [24.5 d](/filings/0000863110-26-000025.md) | [24.5](/filings/0000863110-25-000034.md) | [27.4](/filings/0000863110-25-000055.md) | [29.1](/filings/0000863110-25-000109.md) | [26.9 d](/filings/0000863110-26-000025.md) | [25.9](/filings/0000863110-26-000055.md) | [28.5](/filings/0000863110-26-000076.md) | [30.5](/filings/0000863110-25-000109.md) | [28.0 d](/filings/0000863110-26-000025.md) | [27.8](/filings/0000863110-26-000055.md) | [30.7](/filings/0000863110-26-000076.md) |
| Operating income | $m | [6.7](/filings/0000863110-24-000044.md) | [5.5 d](/filings/0000863110-26-000025.md) | [4.7](/filings/0000863110-25-000034.md) | [7.2](/filings/0000863110-25-000055.md) | [8.6](/filings/0000863110-25-000109.md) | [5.6 d](/filings/0000863110-26-000025.md) | [5.5](/filings/0000863110-26-000055.md) | [7.9](/filings/0000863110-26-000076.md) | [8.6](/filings/0000863110-25-000109.md) | [5.8 d](/filings/0000863110-26-000025.md) | [6.3](/filings/0000863110-26-000055.md) | [8.6](/filings/0000863110-26-000076.md) |
| Interest expense | $m | [2.2](/filings/0000863110-24-000044.md) | [2.2 d](/filings/0000863110-26-000025.md) | [2.2](/filings/0000863110-25-000034.md) | [2.2](/filings/0000863110-25-000055.md) | [2.2](/filings/0000863110-25-000109.md) | [2.2 d](/filings/0000863110-26-000025.md) | [2.2](/filings/0000863110-26-000055.md) | [2.2](/filings/0000863110-26-000076.md) | [2.2](/filings/0000863110-25-000109.md) | [2.2 d](/filings/0000863110-26-000025.md) | [2.2](/filings/0000863110-26-000055.md) | [2.3](/filings/0000863110-26-000076.md) |
| Income tax | $m | [2.2](/filings/0000863110-24-000044.md) | [1.2 d](/filings/0000863110-26-000025.md) | [1.7](/filings/0000863110-24-000020.md) | [1.9](/filings/0000863110-24-000037.md) | [2.4](/filings/0000863110-24-000044.md) | [1.3 d](/filings/0000863110-26-000025.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [5.1](/filings/0000863110-24-000044.md) | [3.5 d](/filings/0000863110-26-000025.md) | [4.4](/filings/0000863110-25-000109.md) | [5.3](/filings/0000863110-25-000109.md) | [6.8](/filings/0000863110-25-000109.md) | [3.8 d](/filings/0000863110-26-000025.md) | [5.4](/filings/0000863110-26-000076.md) | [6.3](/filings/0000863110-26-000076.md) | [7.0](/filings/0000863110-25-000109.md) | [4.1 d](/filings/0000863110-26-000025.md) | [5.9](/filings/0000863110-26-000076.md) | [6.6](/filings/0000863110-26-000076.md) |
| Diluted EPS | $ per share | [0.49](/filings/0000863110-24-000044.md) | not reported | [0.43](/filings/0000863110-25-000034.md) | [0.52](/filings/0000863110-25-000055.md) | [0.66](/filings/0000863110-25-000109.md) | not reported | [0.53](/filings/0000863110-26-000055.md) | [0.61](/filings/0000863110-26-000076.md) | [0.68](/filings/0000863110-25-000109.md) | not reported | [0.57](/filings/0000863110-26-000055.md) | [0.64](/filings/0000863110-26-000076.md) |
| Basic EPS | $ per share | [0.49](/filings/0000863110-24-000044.md) | not reported | [0.43](/filings/0000863110-25-000034.md) | [0.52](/filings/0000863110-25-000055.md) | [0.66](/filings/0000863110-25-000109.md) | not reported | [0.53](/filings/0000863110-26-000055.md) | [0.61](/filings/0000863110-26-000076.md) | [0.68](/filings/0000863110-25-000109.md) | not reported | [0.58](/filings/0000863110-26-000055.md) | [0.64](/filings/0000863110-26-000076.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.5](/filings/0000863110-23-000042.md) | [2.5](/filings/0000863110-25-000020.md) | [9.5](/filings/0000863110-24-000020.md) | [6.3](/filings/0000863110-24-000037.md) | [10.7](/filings/0000863110-24-000044.md) | [1.1](/filings/0000863110-26-000025.md) | [3.7](/filings/0000863110-25-000034.md) | [0.3](/filings/0000863110-25-000055.md) | [0.7](/filings/0000863110-25-000109.md) | [0.1](/filings/0000863110-26-000076.md) | [4.3](/filings/0000863110-26-000055.md) | [9.8](/filings/0000863110-26-000076.md) |
| Current assets | $m | [33.9](/filings/0000863110-23-000042.md) | [30.6](/filings/0000863110-25-000020.md) | [30.8](/filings/0000863110-24-000020.md) | [29.1](/filings/0000863110-24-000037.md) | [34.3](/filings/0000863110-24-000044.md) | [24.5](/filings/0000863110-26-000025.md) | [25.2](/filings/0000863110-25-000034.md) | [22.3](/filings/0000863110-25-000055.md) | [19.6](/filings/0000863110-25-000109.md) | [21.4](/filings/0000863110-26-000076.md) | [26.5](/filings/0000863110-26-000055.md) | [30.8](/filings/0000863110-26-000076.md) |
| Total assets | $m | [767](/filings/0000863110-24-000044.md) | [767](/filings/0000863110-25-000020.md) | [799](/filings/0000863110-25-000034.md) | [783](/filings/0000863110-24-000037.md) | [796](/filings/0000863110-24-000044.md) | [799](/filings/0000863110-26-000025.md) | [809](/filings/0000863110-25-000034.md) | [819](/filings/0000863110-25-000055.md) | [834](/filings/0000863110-25-000109.md) | [851](/filings/0000863110-26-000076.md) | [867](/filings/0000863110-26-000055.md) | [884](/filings/0000863110-26-000076.md) |
| Current liabilities | $m | [27.2](/filings/0000863110-23-000042.md) | [22.4](/filings/0000863110-25-000020.md) | [21.7](/filings/0000863110-24-000020.md) | [22.4](/filings/0000863110-24-000037.md) | [28.0](/filings/0000863110-24-000044.md) | [25.6](/filings/0000863110-26-000025.md) | [25.6](/filings/0000863110-25-000034.md) | [25.6](/filings/0000863110-25-000055.md) | [29.0](/filings/0000863110-25-000109.md) | [33.7](/filings/0000863110-26-000076.md) | [26.2](/filings/0000863110-26-000055.md) | [30.4](/filings/0000863110-26-000076.md) |
| Long-term debt | $m | [176](/filings/0000863110-23-000042.md) | [178](/filings/0000863110-25-000020.md) | [178](/filings/0000863110-24-000020.md) | [177](/filings/0000863110-24-000037.md) | [177](/filings/0000863110-24-000044.md) | [177](/filings/0000863110-26-000025.md) | [176](/filings/0000863110-25-000034.md) | [175](/filings/0000863110-25-000055.md) | [175](/filings/0000863110-25-000109.md) | [174](/filings/0000863110-26-000076.md) | [183](/filings/0000863110-26-000055.md) | [183](/filings/0000863110-26-000076.md) |
| Current portion of debt | $m | not reported | [2.2](/filings/0000863110-25-000020.md) | not reported | not reported | not reported | [2.2](/filings/0000863110-26-000025.md) | not reported | not reported | not reported | [2.1](/filings/0000863110-26-000025.md) | not reported | not reported |
| Shareholders' equity | $m | [230](/filings/0000863110-24-000044.md) | [230](/filings/0000863110-26-000025.md) | [232](/filings/0000863110-25-000109.md) | [234](/filings/0000863110-25-000109.md) | [238](/filings/0000863110-25-000109.md) | [239](/filings/0000863110-26-000076.md) | [242](/filings/0000863110-26-000076.md) | [245](/filings/0000863110-26-000076.md) | [249](/filings/0000863110-25-000109.md) | [250](/filings/0000863110-26-000076.md) | [253](/filings/0000863110-26-000076.md) | [256](/filings/0000863110-26-000076.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.1 d](/filings/0000863110-24-000044.md) | [8.5 d](/filings/0000863110-26-000025.md) | [12.6](/filings/0000863110-25-000034.md) | [6.9 d](/filings/0000863110-25-000055.md) | [10.7 d](/filings/0000863110-25-000109.md) | [6.7 d](/filings/0000863110-26-000025.md) | [11.0](/filings/0000863110-26-000055.md) | [7.9 d](/filings/0000863110-26-000076.md) | [11.0 d](/filings/0000863110-25-000109.md) | [10.5 d](/filings/0000863110-26-000025.md) | [8.6](/filings/0000863110-26-000055.md) | [10.2 d](/filings/0000863110-26-000076.md) |
| Capital expenditure | $m | [16.5 d](/filings/0000863110-24-000044.md) | [13.3 d](/filings/0000863110-26-000025.md) | [8.9](/filings/0000863110-25-000034.md) | [9.5 d](/filings/0000863110-25-000055.md) | [12.6 d](/filings/0000863110-25-000109.md) | [15.0 d](/filings/0000863110-26-000025.md) | [10.4](/filings/0000863110-26-000055.md) | [15.9 d](/filings/0000863110-26-000076.md) | [14.3 d](/filings/0000863110-25-000109.md) | [18.3 d](/filings/0000863110-26-000025.md) | [13.1](/filings/0000863110-26-000055.md) | [12.7 d](/filings/0000863110-26-000076.md) |
| Dividends paid | $m | [3.1 d](/filings/0000863110-24-000044.md) | [3.0 d](/filings/0000863110-26-000025.md) | [3.0](/filings/0000863110-25-000034.md) | [3.0 d](/filings/0000863110-25-000055.md) | [3.0 d](/filings/0000863110-25-000109.md) | [3.1 d](/filings/0000863110-26-000025.md) | [3.1](/filings/0000863110-26-000055.md) | [3.2 d](/filings/0000863110-26-000076.md) | [3.2 d](/filings/0000863110-25-000109.md) | [3.2 d](/filings/0000863110-26-000025.md) | [3.2](/filings/0000863110-26-000055.md) | [3.3 d](/filings/0000863110-26-000076.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.5](/filings/0000863110-23-000042.md) | [9.5](/filings/0000863110-24-000020.md) | [10.0](/filings/0000863110-24-000037.md) | [10.3](/filings/0000863110-24-000044.md) | [10.3](/filings/0000863110-25-000034.md) | [10.3](/filings/0000863110-25-000055.md) | [10.3](/filings/0000863110-25-000109.md) | [10.3](/filings/0000863110-26-000055.md) | [10.3](/filings/0000863110-26-000076.md) | [10.3](/filings/0000863110-25-000109.md) | [10.3](/filings/0000863110-26-000055.md) | [10.3](/filings/0000863110-26-000076.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,761,699 at 2012-05-02, from the cover of the [10-Q filed 2012-05-08](/filings/0000863110-12-000013.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.